Huntsville,
Alabama
December 2, 2005
Food
biotechnologists at Alabama A&M
University have successfully eliminated a major peanut
allergen that causes sometimes fatal reactions in many people
throughout the world.
There
are at least six distinct peanut allergens that pose problems in
some people who eat peanuts or its derivatives, say Dr. Hortense
Dodo (photo) (pronounced with long vowels) and research
colleague Dr. Koffi Konan. Using a process referred to as RNA
Interference (RNAi), the scientists were able to transform
peanut tissues and silence the Ara h2 allergen gene, thus
eliminating one of the proteins which triggers allergic
reactions.
Dodo called peanut allergies the most deadly of
the food allergies. The Ara h2 allergen and other peanut
allergens, for instance, are responsible for causing such
symptoms as hives, swelling, respiratory problems,
gastrointestinal difficulties and anaphylactic shock.
Peanuts represent a more than $4 billion
industry, says Dodo, and they are a cheap source of high quality
proteins, good fats, vitamins and minerals. Moreover,
the crop can be grown “almost anywhere,” she adds.
Why the Increase in Peanut Allergies?
“The number of people experiencing allergic
reactions to peanuts is increasing every year,” commented Dr.
Dodo from one of her labs on the AAMU campus. She noted that
“more and more accidental deaths” occur as people unknowingly
ingest foods that include peanut flour or oil. The tragic death
last week of a 15-year-old Canadian girl is one such example.
Dodo says scientists are not really sure what is
happening that is causing the rise in the number of new cases of
peanut allergies each year. Most of the cases involve young
children, notes Dodo. Some researchers suggest that statistics
were not as prevalent in decades past. Others point to a more
sanitized lifestyle that has caused American immune systems to
lose their bite. But one thing seems certain, notes
Dodo--peanut allergies are not as common in developing
countries.
Permanent Eradication of Peanut Allergy
Admittedly, the road toward the development of
allergen-free peanuts was a long and winding one. Dodo and
Konan say it took some time to refine a process that yielded a
transgenic hypoallergenic peanut plant that produced seeds. The
AAMU researchers applied the RNAi process, which could
permanently eliminate allergens’ accumulation in peanut, and
they finally saw a light at the end of the research tunnel in
February 2005.
Since that time, Dodo and Konan have been growing
subsequent generations of the transgenic plant and testing for
the presence of the most potent peanut allergens, which
theoretically should not re-occur. In the world of peanut
research, a generation could mean six months or longer.
Of course, other scientists are approaching the
peanut allergy problems in a variety of ways, including the
development of methods to treat the allergic patient. Dodo and
Konan, however, prefer to find solutions by looking directly at
“the culprit”—the peanut itself.
“Our goal in developing a hypo-allergenic and
allergen–free peanut is not to push people who are allergic to
peanuts to eat them,” explains Dodo, “but to foster
industry-wide use of the new peanut variety in processed foods
that contain peanuts. So, if a person allergic to peanuts
accidentally eats such foods, doing so should not trigger a
severe reaction or death.”
Studies are currently underway at AAMU, says
Dodo, to determine if the new transgenic peanuts maintain their
nutritional quality. Dr. Dodo is looking for commercial
partners. |